22nd Century Group, Inc. (XXII)

22nd Century Group is pioneering the tobacco harm reduction movement by enabling smokers to take control of their nicotine consumption. Our proprietary non-GMO reduced nicotine tobacco plants were developed using our patented technologies that regulate alkaloid biosynthesis activities resulting in a tobacco plant that contains 95% less nicotine than traditional tobacco plants. Our extensive patent portfolio has been developed to ensure that our high-quality tobacco can be grown commercially at scale. We continue to develop our intellectual property to ensure our ongoing leadership in the tobacco harm reduction movement. We created our flagship low nicotine cigarette products , the VLN cigarette and Pinnacle VLN cigarette using our low nicotine tobacco, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption.

Sector

Health Care

Industry

Medicinal Chemicals and Botanical Products

Exchange

NASDAQ-CM

Region

North America

Website

xxiicentury.com